← Eichor
Condition: Hpv Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hpv Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
Phase 2 · 1 location(s) · Zagazig University · NCT05291845
Pocket Colposcopy Using CARE Algorithm
NA · 1 location(s) · Duke University · NCT06458062
Normalizing Antibody Detection in First-void Urine
Phase N/A · 1 location(s) · Universiteit Antwerpen · NCT06582654
Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After H
Phase 2 · 3 location(s) · Universiteit Antwerpen · NCT07407569
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910
Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vac
Phase 4 · 1 location(s) · Xiamen Innovax Biotech Co., Ltd · NCT07668271
Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Phase 2 · 1 location(s) · KTH Biopharma · NCT07698886
Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
NA · 3 location(s) · University of California, Irvine · NCT07209917
PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia
Phase 2 · 10 location(s) · PapiVax Biotech, Inc. · NCT07454915
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05026138
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189
Multicenter Real-World Study of Hyperthermia in Warts of Special Population
NA · 1 location(s) · First Hospital of China Medical University · NCT06827938
Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.
Phase 4 · 12 location(s) · Labo'Life · NCT04232917
Digital Telecytology for Triage of HPV-Positive Women in Cameroon
NA · 2 location(s) · University Hospital, Geneva · NCT07550010
Psycho-emotional Impact of Preoperative Counselling in Cervico-carcinoma Screening Programs
Phase N/A · 1 location(s) · University of Turin, Italy · NCT06500767
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
NA · 1 location(s) · University of Rochester · NCT06380114
Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT05918510
A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Wome
Phase 3 · 8 location(s) · National Vaccine and Serum Institute, China · NCT05262010
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT04422366
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo
Phase 2 · 1 location(s) · Amplexd Therapeutics, Inc. · NCT07572396
Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota
Phase N/A · 1 location(s) · Centre National de la Recherche Scientifique, France · NCT07199998
Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical I
Phase N/A · 1 location(s) · University Hospital, Bordeaux · NCT04057924
Effect of Different HPV Education Methods on Vaccination Intention in Young Women
NA · 1 location(s) · Emel GÜÇLÜ CİHAN · NCT07420556
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00867269
Playing Game to Learn About Children's Vaccine Project
NA · 1 location(s) · Michigan State University · NCT05984849
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06598475
Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
Phase 2/Phase 3 · 2 location(s) · Western Institute for Veterans Research · NCT05625633
Effectiveness of HPV Vaccine Among Adolescents and Reproductive Women
Phase N/A · 2 location(s) · Mahidol University · NCT06220747
Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart
NA · 1 location(s) · Mazandaran University of Medical Sciences · NCT06737406
People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
Phase N/A · 1 location(s) · University of California, San Francisco · NCT06055868
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.